IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 10 analysts with an average price target of $37.37. This is a potential upside of $12.96 (53.09%) from yesterday's end of day stock price of $24.41.

Immunovant 's activity chart (see below) currently has 159 price targets and 127 ratings on display. The stock rating distribution of IMVT is 84.21% BUY and 15.79% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.68% with an average time for these price targets to be met of 177.39 days.

Highest price target for IMVT is $54, Lowest price target is $17, average price target is $35.75.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 10-Feb-2026. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 16 are a BUY (84.21%), 3 are a HOLD (15.79%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Jul-2020

$35

$10.59 (43.38%)

$35

1 months 4 days ago
(10-Feb-2026)

11/22 (50%)

$8.32 (31.18%)

268

Buy Since 13-Feb-2023

$44

$19.59 (80.25%)

1 months 5 days ago
(09-Feb-2026)

3/9 (33.33%)

$16.51 (60.06%)

119

Hold Since 14-Oct-2025

$22

$-2.41 (-9.87%)

$16

2 months 6 days ago
(08-Jan-2026)

2/5 (40%)

$-4.31 (-16.38%)

35

Buy Since 20-Feb-2024

$34

$9.59 (39.29%)

$33

3 months 23 days ago
(19-Nov-2025)

0/5 (0%)

$10.84 (46.80%)

Buy Since 27-Mar-2024

$54

$29.59 (121.22%)

$54

6 months 10 days ago
(04-Sep-2025)

0/5 (0%)

$37.88 (234.99%)

Show more analysts

Please expand the browser size to see the chart

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 177.39 days on average for the stock forecasts to be realized with a an average price target met ratio 56.68

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa has 0 price targets and 0 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Yasmeen Rahimi with highest potential upside - $32.59

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$17.41

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?